MedPath

Evaluation of Monitoring TECHNOlogies in the PERI-OPerative Care of Cardiac Surgical Patients

Completed
Conditions
C.Surgical Procedure; Cardiac
Right-Sided Heart Failure
Acute Kidney Injury
Postoperative Complications
Respiratory Insufficiency
Interventions
Procedure: Cardiac surgery
Registration Number
NCT02658006
Lead Sponsor
Montreal Heart Institute
Brief Summary

The purpose of this prospective observational cohort study is to evaluate multimodal monitoring technologies in the perioperative care of cardiac surgical patients. Right ventricular pressure tracings, near infrared spectroscopy (NIRS) and transthoracic ultrasonography will be studied for their ability to detect and predict complications such as right ventricular failure, renal failure and respiratory failure.

Detailed Description

The study has 4 main objectives:

1. To determine if right ventricular pressure tracings correlate with other indices of right ventricular failure and with positive fluid balance, renal failure and increased length of stay in the intensive care unit.

2. To determine the prevalence of portal vein pulsatility in the perioperative period and its association with right ventricular failure and positive fluid balance.

3. To determine if Near InfraRed Spectroscopy (NIRS) values correlate with mixed venous oxygen saturation (SvO2) and with poorer post-operative prognosis.

4. To determine the incidence, risk factors and prognosis of respiratory complications of cardiac surgery using transthoracic ultrasonography.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Cardiac surgery performed at the Montreal Heart Institute
  • 18 years old and older
Exclusion Criteria
  • Urgent surgery
  • Pre-operative intra-aortic balloon pump, left ventricular assist device or ECMO
  • Heart transplant
  • Cirrhosis

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Cardiac surgical patientsCardiac surgeryAdult patients having a cardiac surgery at the Montreal Heart Institute
Primary Outcome Measures
NameTimeMethod
Right ventricular failureFirst 24 hours post cardiac surgery
Pulmonary complications30 days

Composite outcome : pneumonia, prolonged mechanical ventilation (more than 24 hours) or clinically significant atelectasis (requiring \> 2L O2).

Acute Renal failure30 days

KDIGO : class I and more

Secondary Outcome Measures
NameTimeMethod
Maximal blood lactate levelsFirst 24h
Fluid balanceFirst 24h

Trial Locations

Locations (1)

Montreal Heart Institute

🇨🇦

Montreal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath